Venetocla/Venetoc Lao version price

Venetoclax is a targeted therapy for chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL) and acute myeloid leukemia (AML). It is understood that there are already several Lao versions of generic drugs of Venekra available on the overseas market. Common manufacturers may include Laos Lucius Pharmaceuticals, Daxiong Pharmaceuticals, ASEAN Pharmaceuticals, etc. The drugs they produce are basically the same as the original drugs in terms of pharmaceutical ingredients, but there are some differences in specifications, manufacturers or prices.

Venetoclaxis a drug called a BCL-2 inhibitor. BCL-2 is a protein involved in regulating cell death in the body. High levels of this protein are found in CLL, SLL and AML cells. This helps these cells live longer. It can also help cells resist chemotherapy. Venectin attaches to the BCL-2 protein and prevents it from working. This causes cancer cells to die. Veneclax usually starts working within a few hours after patients take their first dose. Patients may not notice that venetoclax is working unless they develop symptoms of tumor lysis syndrome (TLS). Patients will have blood tests during treatment to check if Venetoclax is working.

Currently, the Laotian version of the generic version of Venacla is not available in the country. It may be sold in local hospitals in Laos. Taking a box of 100mg*112 tablets as an example, the price of each box may range from RMB 2,000 to more than RMB 3,000 (the price may fluctuate due to the exchange rate). For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.